Skip to main content
. 2020 May 20;21(4):737–741. doi: 10.5811/westjem.2020.5.47658

Table 1.

Inclusion-exclusion criteria for systematic review of studies regarding the use of remdesivir for treatment of COVID-19.

Inclusion Exclusion
1. Human study 1.

  1. In vitro study or

  2. In vivo study (e.g. animal model) or

  3. Other non-human study (unless can be isolated)
2. Remdesivir (GS-5734) included 2. Remdesivir (GS-5734) not included in the article
3.

  1. Case report or

  2. Case series or

  3. Letter of correspondence or

  4. Observational study or

  5. Clinical trial or

  6. Randomized controlled trial

 3.

  1. Literature review or

  2. Systematic review or

  3. Meta-analysis or

4.

  1. Novel coronavirus or

  2. 2019-nCov or

  3. SARS-COV-2 or

  4. COVID-19

 4.

  1. Other pathogen or virus included (e.g. Marburg)

Studies that meet all the inclusion criteria may be included in the systematic review. Studies that meet any of the exclusion criteria should be excluded from the systematic review.